Capricor Therapeutics Inc (CAPR) — Capital Reinvestment Ratio
Capricor Therapeutics Inc (CAPR) has a Capital Reinvestment Ratio of 0.11x as of March 2023, meaning it reinvests 0% of its operating cash flow ($4.21 Million) in capital expenditures ($453.12K). Check Capricor Therapeutics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capricor Therapeutics Inc Capital Reinvestment Ratio (2014–2022)
This chart tracks Capricor Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Capricor Therapeutics Inc.
Annual Capital Reinvestment Ratio for Capricor Therapeutics Inc (2014–2022)
Year-by-year Capital Reinvestment Ratio for Capricor Therapeutics Inc from 2014 to 2022. See CAPR cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.68x | $4.92 Million | $3.36 Million | ▲ +251.3% |
| 2014 | 0.19x | $958.56K | $186.43K | — |